Cary Street Partners Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Cary Street Partners Asset Management's PFE Position: Q3 2024 in Review
Cary Street Partners Asset Management increased its Pfizer (PFE) stake by 7% in Q3 2024, buying an estimated $36.1K and bringing the position to 18,865 shares worth $546K. The position accounts for 0.07% of the portfolio, ranked #145.
Cary Street Partners Asset Management first reported a position in PFE in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.21M in Q2 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Cary Street Partners Asset Management held 18,865 shares of Pfizer worth $546K as of Q3 2024.
- Cary Street Partners Asset Management bought 1,238 Pfizer shares in Q3 2024, an estimated $36.1K.
- Pfizer made up 0.07% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #145 holding.
- Cary Street Partners Asset Management first reported a position in Pfizer in Q1 2021 and has held it in 15 quarters since.
- Cary Street Partners Asset Management's Pfizer position peaked at $1.21M in Q2 2022.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.